Director/PDMR Shareholding
Summary by AI BETAClose X
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it has been notified of the following transactions in the Company's Ordinary 1p shares undertaken on behalf of directors / persons discharging managerial responsibility ('PDMRs') under the Company's Global Bonus Scheme.
Under the terms of the Company's Remuneration Policy, one third of any annual bonus payable to the Executive Directors each year, net of tax and national insurance, will be used to purchase shares which the Executive Directors are required to hold for at least two years from the date of acquisition.
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name |
Ije Nwokorie |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Dr. Martens plc |
||||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||||
|
b) |
Nature of the transaction |
Purchase of Ordinary shares under the FY25 Global Bonus Scheme |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information
|
|
||||||
|
e) |
Date of the transaction |
2026-06-25
|
||||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
Giles Wilson |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR (Chief Financial Officer) |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Dr. Martens plc |
||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary shares under the FY25 Global Bonus Scheme |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information
|
|
||||
|
e) |
Date of the transaction |
2026-06-25
|
||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||
For further information please contact:
Paul Rolling
Head of Secretariat
+44 (0)7584 243562
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago Oxford Nanopore Technologies
- 4 hours ago AVI Global Trust
- 4 hours ago LSL Property Services
- 4 hours ago Bluebird Merchant Ventures (DI)
- 4 hours ago Power Probe PLC